Trial Profile

A clinical trial of SPH4480 for the treatment of diabetes mellitus in China

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 10 May 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs I 024 (Primary)
Indications Diabetes mellitus
Focus Pharmacokinetics
Sponsors Shanghai Pharmaceutical Group

Most Recent Events

10 May 2022 New trial record
10 Jul 2018 According to a Shanghai Pharmaceutical Group media release, the clinical trial application was officially accepted by the State Food and Drug Administration. The application acceptance numbers are: CXHL1700287 Shanghai, CXHL1700289 Shanghai, CXHL1700288 Shanghai.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com